Make a Donation
Help fund crucial research on ovarian and related gynecologic cancer.
Read more about Make a Donation Support better outcomes for patients
Help us invest in life-saving research, offer hope and comfort to patients and their families, and continue to drive awareness and education.
Help fund crucial research on ovarian and related gynecologic cancer.
Read more about Make a Donation Support better outcomes for patients
Channel your passion into action and fundraise for OCRA
Link: Links to main Make a Donation Page
Read more about Fundraise for OCRA Inspire hope through fundraising
Read more about Estate Planning Learn about estate planning benefits
Read more about Stocks & Financial Gifts Make a financial gift now
Thanks to your support, we can continue to fund groundbreaking research, help patients and their loved ones through every step of their journey, and advocate on behalf of those who need it most.
Our Partners in Science program offers donors the unique opportunity to fund research that speaks to their personal passions. By sponsoring a scientist of their choice (donors can choose based on an area of research, affiliated institution, or even a particular geographic region), they enjoy the satisfaction of supporting our most innovative and promising scientists, while also receiving updates on their sponsored scientist's progress and breakthroughs.
OCRA believes we are stronger together. Through strategic partnerships, we can maximize our impact and help find a cure for ovarian and all gynecologic cancers.
In 2025, Ovarian Cancer Research Alliance (OCRA) invested more than $10.8 million toward scientific research—part of our $14.5 million commitment to strengthen the community through research, patient support, education and advocacy. This year’s investment represents OCRA’s broadest scope to date, encompassing not only our renowned grant programs but also global collaborations leveraging artificial intelligence (AI) … Continued
KVIA-TV ABC-7 News El Paso recently featured OCRA-funded researcher Daniel Heller, PhD, and his team at Memorial Sloan Kettering Cancer Center, whose innovative work is bringing new hope for detecting ovarian cancer at its earliest stages through a simple blood test. Dr. Heller’s research lab is developing a liquid biopsy that uses nanosensors and artificial intelligence (AI) to measure multiple proteins … Continued
This article was updated in October 2025 to reflect NCCN’s release of the 2025 Guidelines for Uterine Cancer Patients. OCRA is a proud sponsor of the 2025 Patient Guidelines for Cervical, Ovarian, and Uterine Cancer. We believe ensuring access to clear, understandable information is critical. NCCN provides wonderful guides for anyone newly diagnosed to help … Continued
Get email updates about research news, action alerts, and ways to join the fight.